Overview

  • Product nameMethyllycaconitine citrate (MLA)
  • Description
    α7 Nicotinic receptor antagonist
  • Alternative names
    • MLA
  • Biological descriptionPotent, selective antagonist at α7-containing nicotinic receptors.

    Also available in simple stock solutions (ab146684) - add 1 ml of water to get an exact, ready-to-use concentration.
  • Purity> 98%

Properties

    References for Methyllycaconitine citrate (MLA) (ab120072)

    This product has been referenced in:
    • Chilton M  et al. Behavioral consequences of methyllycaconitine in mice: a model of alpha7 nicotinic acetylcholine receptor deficiency. Life Sci 74:3133-9 (2004). Read more (PubMed: 15081578) »
    • Davies AR  et al. Characterisation of the binding of [3H]methyllycaconitine: a new radioligand for labelling alpha 7-type neuronal nicotinic acetylcholine receptors. Neuropharmacology 38:679-90 (1999). Read more (PubMed: 10340305) »
    • Whiteaker P  et al. An autoradiographic study of the distribution of binding sites for the novel alpha7-selective nicotinic radioligand [3H]-methyllycaconitine in the mouse brain. Eur J Neurosci 11:2689-96 (1999). Read more (PubMed: 10457165) »

    See all 4 Publications for this product

    Product Wall

    There are currently no Abreviews or Questions for ab120072.
    Please use the links above to contact us or submit feedback about this product.

    Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE, NOT FOR USE IN HUMANS"